SCHEMBL29698237

SCHEMBL29698237

CCOc1cc(C(C)O)ncc1Cl

nearest known ligand 0.38

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 3/20 0.38
CYP2D6 P10635 2/20 0.38
SMN1; SMN2 Q16637 3/20 0.36
LMNA P02545 2/20 0.36
POLB P06746 1/20 0.36
HTT P42858 1/20 0.36
TP53 P04637 2/20 0.35
STING1 Q86WV6 1/20 0.35
AOC3 Q16853 1/20 0.35
RORC P51449 1/20 0.35
ALDH1A1 P00352 1/20 0.35
CYP2C19 P33261 2/20 0.34
NPC1 O15118 1/20 0.34
MAPT P10636 1/20 0.34
RAB9A P51151 1/20 0.34
CNR2 P34972 1/20 0.34
KDM4E B2RXH2 1/20 0.33
S1PR1 P21453 1/20 0.33
S1PR3 Q99500 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22978620 1.00 CYP1A2 (0.38) CYP1A2CYP2D6SMN1; SMN2LMNAPOLB
SCHEMBL22978645 0.83 TP53 (0.35) CYP1A2CYP2D6LMNAPOLBHTT
SCHEMBL29743745 0.80 PTGS1 (0.37) HTTAOC3ALDH1A1S1PR1
SCHEMBL29743753 0.80 PTGS1 (0.37) HTTAOC3ALDH1A1S1PR1
SCHEMBL24510135 0.80 PTGS1 (0.37) HTTAOC3ALDH1A1S1PR1
SCHEMBL29743750 0.80 PTGS1 (0.37) HTTAOC3ALDH1A1S1PR1
SCHEMBL22978483 0.80 PTGS1 (0.37) HTTAOC3ALDH1A1S1PR1
SCHEMBL30525607 0.76 KCNJ1 (0.45) CYP1A2SMN1; SMN2LMNAALDH1A1S1PR1
SCHEMBL22990493 0.76 KCNJ1 (0.45) CYP1A2SMN1; SMN2LMNAALDH1A1S1PR1
SCHEMBL17894000 0.74 AOC3 (0.41) CYP1A2LMNAHTTAOC3RORC

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4010334-A1 HETEROCYCLIC WDR5 INHIBITORS AS ANTI-CANCER COMPOUNDS Novartis AG (CH) 2022-06-15 EP disclosed